The abstract is read at the publisher; the summary is JClub's.
ISGylation, driven by interferon-induced ISG15 and its UBE1L–UBE2L6–E3 cascade, is reversed by USP18 deISGylation, shaping multiple cellular pathways.
- Why it matters: Understanding how ISG15 is attached and removed is crucial because dysregulated ISGylation is linked to cancer, infection, neurodegenerative disorders, and inflammatory diseases.
- What they did: The field uses chemical biology and mass spectrometry-based proteomics to identify (de)ISGylation enzymes and to map ISGylated proteins and modification sites.
- The result: These approaches enable characterization of ISGylation’s molecular targets and mechanisms, supporting links between altered ISGylation and broad disease relevance.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.